Timothy Mant

Safety and Efficacy of RNAi Therapy for Transthyretin Amyloidosis

Teresa Coelho, David Adams, Ana Silva et al. · New England Journal of Medicine · 2013 · 947 citations · Full text

Effect of an RNA interference drug on the synthesis of proprotein convertase subtilisin/kexin type 9 (PCSK9) and the concentration of serum LDL cholesterol in healthy volunteers: a randomised, single-blind, placebo-controlled, phase 1 trial

Kevin Fitzgerald, Maria Frank-Kamenetsky, Svetlana Shulga‐Morskaya et al. · The Lancet · 2013 · 571 citations · Full text

Metabolic Syndrome, Oxysterol, Biochemistry +9

Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.

Marius Rademaker, E D Cooke, N. E. Almond et al. · BMJ · 1989 · 231 citations · Full text

Clinical Safety of SonoVue™, a New Contrast Agent for Ultrasound Imaging, in Healthy Volunteers and in Patients with Chronic Obstructive Pulmonary Disease

Daniela Bokor, John B. Chambers, P. J. Rees et al. · Investigative Radiology · 2001 · 126 citations

Phase I Trial of ISIS 104838, a 2′-Methoxyethyl Modified Antisense Oligonucleotide Targeting Tumor Necrosis Factor-α

K. Lea Sewell, Richard S. Geary, Brenda F. Baker et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 120 citations